Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
10/17/2000 | US6133033 Method for in vitro selection of potato clones resistant to blackspot bruising and the potatoes produced therefrom |
10/17/2000 | US6133030 Co-cultivation of cells in a micropatterned configuration |
10/17/2000 | US6133029 Replication defective viral vectors for infecting human cells |
10/17/2000 | US6133025 Nucleic acid for episomal replication in mammalian cells; includes a cis-acting origin of replication sequence and the nuclear antigen 1 sequence linked to a promoter; for gene therapy |
10/17/2000 | US6133015 HHV-8+ lymphoma cell line which is HIV-, CMV-, EBV-, and which produces large amounts of uncontaminated HHV-8 virus |
10/17/2000 | US6133007 Phosphodiesterase 8A |
10/17/2000 | US6133006 Nucleotide sequence coding an enzmatic polypeptide associated with signal transduction; for the diagnosis and treatment of osteoporosis, inflammation, skin disorders, asthma, nervous system disorders, cancer, eating disorders and infections |
10/17/2000 | US6132992 Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell |
10/17/2000 | US6132987 Polypeptide associated with macrophages; for diagnosis and treatment of inflammation, arthritis and atherosclerosis |
10/17/2000 | US6132983 Microorganismal protein with enzymatic activity associated with luminescence |
10/17/2000 | US6132980 Antibodies specific for TRP-2 a human tumor antigen recognized by cytotoxic T lymphocytes |
10/17/2000 | US6132979 Cytotoxicity testing method |
10/17/2000 | US6132973 Nucleotide sequence coding protein associated with gene expression; for the diagnosis, prevention, and treatment of defects associated with cell proliferation |
10/17/2000 | US6132966 Enzymatic nucleic acid which specifically prevents viral replication; for the treatment of transformed hepatocytes and suppression of viral infection humans, animals and primates |
10/17/2000 | US6132962 Plasmid coding ribozyme; for the prevention of viral infection |
10/17/2000 | US6132960 Envelope polypeptide; for the detection of plant parasite |
10/17/2000 | US6132732 Parvovirus capsids |
10/17/2000 | US6132728 Hedgehog-derived polypeptides |
10/17/2000 | US6132718 Using a vaccine comprising antibodies and anti-idiotype antibodies that mimic an epitope of antigen that is associated with a tumor or infectious agent. |
10/17/2000 | US6132713 Arginine deiminase derived from mycoplasma arthritidis and polymer conjugates containing the same |
10/17/2000 | US6132708 Liver regeneration using pancreas cells |
10/17/2000 | CA2117303C Anti-cancer immunotherapeutic vector constructs |
10/17/2000 | CA1341123C Filamentous hemagglutinin of b. pertussis |
10/17/2000 | CA1341119C Human erythroid-specific transcriptional enhancer |
10/17/2000 | CA1341118C Nucleic acid and methods for the synthesis of novel decay accelerating factor compositions |
10/17/2000 | CA1341117C Genetically engineered plant cells and plants exhibiting resistance to glutamine synthetase inhibitors, dna fragments and recombinants for use in the production of said cells and plants |
10/12/2000 | WO2000060357A1 Tandem immuno-assay for cancer |
10/12/2000 | WO2000060109A1 Amplification of cyp24 and uses thereof |
10/12/2000 | WO2000060100A1 Dsp-9 dual-specificity map kinase phosphatase |
10/12/2000 | WO2000060099A1 Dsp-4 dual-specificity map kinase phosphatase |
10/12/2000 | WO2000060098A1 Dsp-7 dual-specificity map kinase phosphatase |
10/12/2000 | WO2000060095A2 Enzymes of the biosynthetic pathway for the production of triacylglycerol and recombinant dna molecules encoding these enzymes |
10/12/2000 | WO2000060090A1 Compounds and methods for the diagnosis and treatment of b. microti infection |
10/12/2000 | WO2000060086A1 Pathogen inducible promoter |
10/12/2000 | WO2000060082A2 Vesicle associated proteins |
10/12/2000 | WO2000060080A2 Molecules of the immune system |
10/12/2000 | WO2000060077A2 Compounds for therapy and diagnosis of lung cancer and methods for their use |
10/12/2000 | WO2000060076A2 Compositions for the treatment and diagnosis of breast cancer and methods for their use |
10/12/2000 | WO2000060066A1 Protein-protein from s. cerevisiae and methods of using same |
10/12/2000 | WO2000060063A1 Lipase variant |
10/12/2000 | WO2000060061A2 Transgenic plant resistant to mycotoxins and methods |
10/12/2000 | WO2000060060A2 Polypeptides having alkaline alpha-amylase activity and nucleic acids encoding same |
10/12/2000 | WO2000060059A2 Alpha-amylase variants |
10/12/2000 | WO2000060058A2 Polypeptides having alkaline alpha-amylase activity and nucleic acids encoding same |
10/12/2000 | WO2000060055A1 Modified dendritic cells and uses therefor |
10/12/2000 | WO2000060054A1 Pharmaceutical compositions comprising circulating blood cells, preferably monocytes and uses thereof |
10/12/2000 | WO2000060052A1 A method for altering the metabolism of plant |
10/12/2000 | WO2000060051A2 Arpe-19 as a platform cell line for encapsulated cell-based delivery |
10/12/2000 | WO2000060050A2 Recombinant influenza viruses for vaccines and gene therapy |
10/12/2000 | WO2000059944A1 A monoclonal antibody against estrogen stimulated leucine aminopeptidase |
10/12/2000 | WO2000059943A2 MONOCLONAL ANTIBODIES AGAINST HUMAN PROTEIN Mcm3, PROCESS FOR THEIR PRODUCTION, AND THEIR USE |
10/12/2000 | WO2000059942A2 Human obesity protein binding protrein-2 homolog and uses thereof |
10/12/2000 | WO2000059941A1 Purposeful movement of human migratory cells away from an agent source |
10/12/2000 | WO2000059940A2 Platelet-derived growth factor related gene and protein |
10/12/2000 | WO2000059936A1 Human neurogenin 3-encoding nucleotide sequences |
10/12/2000 | WO2000059933A2 HUMAN MESENCHYMAL DNAs AND EXPRESSION PRODUCTS |
10/12/2000 | WO2000059919A1 ANTISENSE MODULATION OF p38 MITOGEN ACTIVATED PROTEIN KINASE EXPRESSION |
10/12/2000 | WO2000059916A1 Compounds selectively inhibiting gamma 9 delta 2 t lymphocytes |
10/12/2000 | WO2000059618A1 Method for populating substrates with biological cells and populating devices that can be used therefor |
10/12/2000 | WO2000059534A1 Method and compositions for preventing or reducing hiv infection by use of inhibitors for leucine aminopeptidase |
10/12/2000 | WO2000059525A2 USE OF ErbB RECEPTOR LIGANDS IN TREATING DIABETES |
10/12/2000 | WO2000059515A2 Immunomodulating polymers |
10/12/2000 | WO2000037494A3 Chlamydia trachomatis antigens |
10/12/2000 | WO2000036129A8 Enhanced protein production in higher plants by n-terminal fusion of a ubiquitin or a cucumber mosaic virus coat protein peptide |
10/12/2000 | WO2000034491A3 An improved efficiency agrobacterium-mediated plant transformation method |
10/12/2000 | WO2000028058A3 Transcriptional activator lec1 nucleic acids, polypeptides and their uses |
10/12/2000 | WO2000025722A3 ENHANCED VACCINES COMPRISING SELF AND NON-SELF IgE PORTIONS OR DIMERIC ANTIGENS |
10/12/2000 | WO2000023594A9 BIOACTIVE PEPTIDES AND PEPTIDE DERIVATIVES OF PARATHYROID HORMONE (PTH) AND PARATHYROID HORMONE-RELATED PEPTIDE (PTHrP) |
10/12/2000 | WO2000020587A3 Cancer associated antigens and uses therefor |
10/12/2000 | WO2000017322A9 Electroactive materials for stimulation of biological activity of cells |
10/12/2000 | WO2000017232A3 Regulatory protein from human keratinocytes |
10/12/2000 | WO2000015790A9 Leptin induced genes |
10/12/2000 | WO1999064594A9 Genes and gene expression products that are differentially regulated in prostate cancer |
10/12/2000 | WO1999058659A9 Methods and compositions for expression of transgenes in plants |
10/12/2000 | WO1999057246A8 Animal cell culture media comprising non-animal or plant-derived nutrients |
10/12/2000 | WO1999041376A8 Retinoblastoma protein complexes and retinoblastoma interacting proteins |
10/12/2000 | WO1997036919A3 Cytokine designated lerk-8 |
10/12/2000 | DE19916140A1 Carotinhydroxylase und Verfahren zur Herstellung von Xanthophyllderivaten Carotene hydroxylase and method of producing Xanthophyllderivaten |
10/12/2000 | DE10004815A1 Human sodium-phosphate cotransporter Npt2B, useful e.g. for identifying agents for treating hyper- and hypo-phosphatemia, and related nucleic acid |
10/12/2000 | CA2368017A1 Use of erbb receptor ligands in treating diabetes |
10/12/2000 | CA2367403A1 Dsp-9 dual-specificity map kinase phosphatase |
10/12/2000 | CA2367378A1 Molecules of the immune system |
10/12/2000 | CA2367109A1 Dsp-4 dual-specificity map kinase phosphatase |
10/12/2000 | CA2367104A1 Dsp-7 dual-specificity map kinase phosphatase |
10/12/2000 | CA2366895A1 Immunomodulating polymers |
10/12/2000 | CA2365961A1 Human neurogenin 3-encoding nucleotide sequences |
10/12/2000 | CA2365548A1 Protein-protein from s. cerevisiae and methods of using same |
10/12/2000 | CA2365526A1 Recombinant influenza viruses for vaccines and gene therapy |
10/12/2000 | CA2365438A1 Alpha-amylase variants |
10/12/2000 | CA2365421A1 Vesicle associated proteins |
10/12/2000 | CA2365413A1 Pathogen inducible promoter |
10/12/2000 | CA2365221A1 Compositions for the treatment and diagnosis of breast cancer and methods for their use |
10/12/2000 | CA2365040A1 Hob-bp2h compositions, methods and uses thereof |
10/12/2000 | CA2303702A1 Growth hormone and growth hormone releasing hormone compositions |
10/11/2000 | EP1043399A2 Hepatitis C Virus cell culture system |
10/11/2000 | EP1043335A1 Monoclonal antibody against connective tissue growth factor and medicinal uses thereof |
10/11/2000 | EP1043333A1 NOVEL POLYPEPTIDES, cDNAS ENCODING THE SAME AND UTILIZATION THEREOF |
10/11/2000 | EP1042674A1 148 human secreted proteins |
10/11/2000 | EP1042498A1 A method of finding agonist and antagonist to human 11cb splice variant |
10/11/2000 | EP1042494A1 Adeno-associated virus and adenovirus chimeric recombinant viruses useful for the integration of foreign genetic information into the chromosomal dna of target cells |